Critical appraisal of Chinese 2017 guideline on the management of hepatocellular carcinoma.
about
Hepatocellular carcinoma: one world, one cancer-different guidelines?Comparison of hepatic resection and transarterial chemoembolization for UICC stage T3 hepatocellular carcinoma: a propensity score matching study.Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosis.Long non-coding RNA DSCR8 acts as a molecular sponge for miR-485-5p to activate Wnt/β-catenin signal pathway in hepatocellular carcinomaTrends in hepatocellular carcinoma research from 2008 to 2017: a bibliometric analysisSearching for common ground in a global disease
P2860
Critical appraisal of Chinese 2017 guideline on the management of hepatocellular carcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Critical appraisal of Chinese ...... t of hepatocellular carcinoma.
@en
Critical appraisal of Chinese ...... t of hepatocellular carcinoma.
@nl
type
label
Critical appraisal of Chinese ...... t of hepatocellular carcinoma.
@en
Critical appraisal of Chinese ...... t of hepatocellular carcinoma.
@nl
prefLabel
Critical appraisal of Chinese ...... t of hepatocellular carcinoma.
@en
Critical appraisal of Chinese ...... t of hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1476
Critical appraisal of Chinese ...... nt of hepatocellular carcinoma
@en
P2093
Di-Yang Xie
Zheng-Gang Ren
P2860
P304
P356
10.21037/HBSN.2017.11.01
P50
P577
2017-12-01T00:00:00Z